Dronabinol

• US Cannabis Regulation: What It Means for Naturopathic Doctors (30 Sep 2024)
  
• Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review (30 Sep 2024)
  
• Cannabinoids in the Older Person: A Literature Review (26 Sep 2024)
  
• The Void in Clinician Counseling of Cannabis Use (24 Sep 2024)
  
• Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions (23 Sep 2024)
  
• Chemical Characteristics, Therapeutic Uses, and Legal Aspects of the Cannabinoids of Cannabis sativa: A Review (16 Sep 2024)
  
• ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology (16 Sep 2024)
  
• Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective (16 Sep 2024)
  
• The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products (03 Sep 2024)
  
• Prenatal cannabinoid exposure: why expecting individuals should take a pregnancy pause from using cannabinoid products (02 Sep 2024)
  
• Potential perioperative cardiovascular outcomes in cannabis/cannabinoid users. A call for caution (02 Sep 2024)
  
• Patients’ perspectives on prescription cannabinoid therapies: a cross-sectional, exploratory, anonymous, one-time web-based survey among German patients (02 Sep 2024)
  
• Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality (02 Sep 2024)
  
• An answered call for aid? Cannabinoid clinical framework for the opioid epidemic (02 Sep 2024)
  
• Cannabinoid-Based Ocular Therapies and Formulations (29 Aug 2024)
  
• Exploring the Potential of Cannabinoid Nanodelivery Systems for CNS Disorders (28 Aug 2024)
  
• Comparison of the Cannabinoid and Terpene Profiles in Commercial Cannabis from Natural and Artificial Cultivation (28 Aug 2024)
  
• CANNabinoid Drug Interaction Review (CANN-DIR™) (28 Aug 2024)
  
• Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products (20 Aug 2024)
  
• Safety Considerations in Cannabinoid-Based Medicine (20 Aug 2024)
  
• Cannabinoid Delivery Systems for Pain and Inflammation Treatment (19 Aug 2024)
  
• Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis (24 May 2024)
  
• Zebrafish as an Animal Model in Cannabinoid Research (02 Sep 2023)
  
• Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids (27 Feb 2023)
  
• Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells (27 Nov 2022)
  
• Considerations for Cannabinoids in Perioperative Care by Anesthesiologists (13 Aug 2022)
  
• Converting Sugars into Cannabinoids—The State-of-the-Art of Heterologous Production in Microorganisms (05 Aug 2022)
  
• Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders (05 Aug 2022)
  
• The Medicinal Natural Products of Cannabis sativa Linn.: A Review (31 Jul 2022)
  
• Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)
  
• Differentiating Cannabis Products: Drugs, Food, and Supplements (31 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Patient Version (21 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Health Professional Version (21 Jul 2022)
  
• Cannabis and Cancer, Part 1: Despite Lack of Evidence, Cannabis Products Being Widely Used (21 Jul 2022)